Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Gabriel Lazaro-Munoz, J.D., Ph.D.

Concepts (12)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Gabriel Lazaro-Munoz's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Gabriel Lazaro-Munoz has written about over time.
Bioethical Issues, 1 publications between 2020 and 2020, average publication date February 2020. Ethics, Research, 1 publications between 2020 and 2020, average publication date February 2020. Genetic Testing, 1 publications between 2020 and 2020, average publication date February 2020. Genomics, 1 publications between 2020 and 2020, average publication date February 2020. Research Design, 1 publications between 2020 and 2020, average publication date February 2020. Research Personnel, 1 publications between 2020 and 2020, average publication date February 2020. Humans, 2 publications between 2020 and 2022, average publication date May 2021. Cognition, 1 publications between 2022 and 2022, average publication date August 2022. Mental Disorders, 1 publications between 2022 and 2022, average publication date August 2022. Multifactorial Inheritance, 1 publications between 2022 and 2022, average publication date August 2022. Phenotype, 1 publications between 2022 and 2022, average publication date August 2022. Risk Factors, 1 publications between 2022 and 2022, average publication date August 2022.

To see the data from this visualization as text, click here.
Lazaro-Munoz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (12)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.